Background
==========

The wrist region is one of the most complex joints of the human body, and it is prone to deformity and functional impairment in juvenile idiopathic arthritis (JIA) \[[@B1],[@B2]\] and is difficult to examine clinically. Inflammation in the wrist region is an indicator of poor outcome in JIA \[[@B3]\]. In the first detailed account of the natural history of wrist arthritis in children, Chaplin and colleagues \[[@B4]\] described late changes, visualized on plain radiographs, in 59% of the patients they studied. The trend towards early suppression of inflammation has probably improved the outcomes in many patients with JIA \[[@B5]\], but it has also increased the need for more sensitive imaging techniques.

The aim of the present study was to investigate the usefulness of ultrasonography (US) with Doppler in JIA, focusing on diagnosis of synovitis, guidance of steroid injections, and follow-up examinations of the wrist region.

Methods
=======

This study was conducted during 2009 and 2010 at the Department of Pediatrics, University of Copenhagen, Denmark. Patients at the Pediatric Rheumatology Outpatient Clinic, Rigshospitalet, Copenhagen, were consecutively invited to participate. The inclusion criterion was having arthritis in the wrist, which the clinician considered would benefit from intra-articular steroid therapy. Fourteen children with 18 wrists with active arthritis consented to take part. Three of those subjects were excluded after the initial US because they did not fulfill the participation requirements to show up at follow-up appointments, leaving a total of 11 children and 15 wrists for evaluation. Demographic features and the results of the clinical and laboratory assessments performed are summarized in Table [1](#T1){ref-type="table"}.

###### 

Clinical and laboratory assessment of 11 JIA patients with 15 symptomatic wrists\*

  Characteristic                                                              Number (%)   Median   Range
  ------------------------------------------ -------------------------------- ------------ -------- ----------
  Sex                                                                                               
                                                                                                    
                                             Male                             1 (9%)                
                                                                                                    
                                             Female                           10 (91%)              
                                                                                                    
  Subgroups                                                                                         
                                                                                                    
                                             Oligoarthritis                   5 (46%)               
                                                                                                    
                                             RF-negative polyarthritis        2 (18%)               
                                                                                                    
                                             Undifferentiated arthritis       2 (18%)               
                                                                                                    
                                             Enthesitis related arthritis     1 (9%)                
                                                                                                    
                                             Systemic                         1 (9%)                
                                                                                                    
  Age at injection, years                                                                  12.5     2-16
                                                                                                    
  Disease duration, years                                                                  4.8      0.8-13.5
                                                                                                    
  Number of joints (n = 15) with                                                                    
                                                                                                    
                                             Swelling                         13 (87%)              
                                                                                                    
                                             Pain                             14 (93%)              
                                                                                                    
                                             Limited range of motion          15 (100%)             
                                                                                                    
                                             Active arthritis                 15 (100%)             
                                                                                                    
  VAS wrist pain patient/parent, cm                                                        4.0      0.2-6.0
                                                                                                    
  VAS global assessment patient/parent, cm                                                 0.5      0-3.7
                                                                                                    
  VAS global assessment physician, cm                                                      2.9      1.5-7.2
                                                                                                    
  CRP level, mg/l                                                                          3        0-22
                                                                                                    
  ESR, mm/h                                                                                15       4-48
                                                                                                    
  HLA B27 positive, number of patients                                        2 (18%)               
                                                                                                    
  ANA positive, number of patients                                            4 (36%)               
                                                                                                    
  RF positive, number of patients                                             1 (9%)                
                                                                                                    
  Drug therapies                                                                                    
                                                                                                    
                                             MTX                              5 (45%)               
                                                                                                    
                                             MTX + Etanercept                 1 (9%)                
                                                                                                    
                                             MTX + Systemic corticosteroids   1 (9%)                

\* ANA = antinuclear antibodies; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; HLA = human leukocyte antigen; MCTD = Mixed connective tissue disease; MTX = Methotrexate; RF = rheumatoid factor; VAS = visual analogue scale

Ten of the 11 children (91%) were female, and the median age was 12.5 years (range 2-16 years). Five had oligoarticular (oligo) JIA, two had polyarticular (poly) JIA, two had undifferentiated arthritis, one had enthesitis related arthritis (ERA) and one systemic JIA. At the time of inclusion, seven had ongoing systemic treatment: five with methotrexate, one with methotrexate and etanercept, and one with methotrexate and systemic corticosteroids (prednisolone 0.1 mg/kg). One patient had received an intra-articular steroid injection within the previous 3 months, but not in the arthritic wrist or the same extremity.

The local research ethics committee approved the study. All parents gave informed consent for their children to participate, and oral agreement was obtained from the children themselves.

Clinical and US assessment
--------------------------

Patients who had previously been diagnosed with JIA based on the revised criteria of the International League of Associations for Rheumatology (ILAR, 2004) \[[@B6]\] were examined by either of two experienced pediatric rheumatologists for clinical signs of involvement of the wrists. The following clinical variables were recorded: swelling, pain assessed by the patient/parent visual analogue scale (VAS, 0 - 10 cm), tenderness to palpation, pain on motion, and limited range of motion.

On the same day, an initial US examination was performed on the patients with clinically active arthritis, which the ILAR defines as swelling within a joint or a limited range of joint movement with joint pain or tenderness. The US examination was conducted by a radiologist specialized in musculoskeletal US using a Logiq 9 scanner (GE Healthcare, Chalfont St. Gilles, UK) equipped with a 16-4 MHz linear transducer. The wrist of the child was imaged dorsally and palmarly with a slight palmar or dorsal flexion. B-mode US was performed to detect structural abnormalities, and color Doppler to identify hyperemia. The radio-carpal and midcarpal compartments were examined by scanning in a dorsal-longitudinal plane, and tendon sheaths (specified in Table [2](#T2){ref-type="table"}) were investigated in a transversal and a longitudinal plane. The Outcome Measures in Rheumatology Clinical Trials (OMERACT) definitions for US pathology (joint effusion, synovial hypertrophy, bone erosions and tenosynovitis) in RA \[[@B7]\] were used, and for each of the compartments the presence/absence of these signs of pathology were registered. The findings of the color Doppler examination were assessed as presence or absence of hyperemia \[[@B8]\]. Color Doppler settings were standardized as follows: the pulse repetition frequency (PRF) was 0.6 KHz, the color Doppler gain was set just below the level at which noise appeared, and the wall filter was very low (65 Hz). US synovitis/tenosynovitis was defined as synovial hypertrophy with or without synovial vascularization, and with or without effusion.

###### 

US diagnosis of tenosynovitis in 15 wrists before steroid injection

  Tendon sheath compartments examined                     Number with tenosynovitis
  ------------------------------------------------------- ---------------------------
  Extensor                                                
                                                          
  abductor pollicis longus and extensor pollicis brevis   1
                                                          
  extensor carpi radialis longus and brevis               2
                                                          
  extensor pollicis longus                                1
                                                          
  extensor digitorum communis                             3
                                                          
  extensor digiti minimi                                  3
                                                          
  extensor carpi ulnaris                                  3
                                                          
  Flexor                                                  
                                                          
  flexor carpi radialis                                   3
                                                          
  flexor pollicis longus                                  2
                                                          
  flexor digitorum superficialis and profundus            2

The dorsal synovial recesses of the radio-carpal and midcarpal joints visualized by US were considered normal if they were thin (Figure [1a-c](#F1){ref-type="fig"}) or impossible to visualize, and as hypertrophic if they were thick or rounded (Figure [2a-d](#F2){ref-type="fig"}). We also registered the presence/absence of bone erosions, defined as an intraarticular discontinuity of the bone surfaces, visible in 2 perpendicular planes \[[@B7]\].

![**The normal aspect of the dorsal synovial recesses of the radio-carpal and midcarpal joints**. **a**Drawing of the thin dorsal recesses of the radio-carpal (rc) and midcarpal (mc) joints, pointing distally. Lun = lunate bone; Cap = capitate bone. **b, c**Dorsal sagittal US scan showing a thin hypoechoic radio-carpal recess (**b**, arrow) without hyperemia on color Doppler examination (**c**).](1546-0096-10-11-1){#F1}

![**Hypertrophic synovial recesses of the radio-carpal and midcarpal joints**. **a, b**Drawings of hypertrophic thickened (**a**) and rounded pseudotumoral (**b**) dorsal recesses of the radio-carpal (rc) and midcarpal (mc) joints. **c**Dorsal sagittal US scan of a hypoechoic thickened radio-carpal recess (1). **d**Dorsal sagittal US scan of the wrist of a 2-year-old girl in which the hypoechoic rounded radio-carpal recess (arrow) is difficult to distinguish from the hypoechoic cartilage of the radius and navicular bones. Lun = lunate bone; Cap = capitate bone.](1546-0096-10-11-2){#F2}

The results in this study are presented as absolute qualitative values without any statistical calculations due to the small size of the sample.

US-guided steroid injection
---------------------------

For each patient, the clinician and the radiologist reached a consensus decision regarding whether compartments should be given injections and, if so, which ones. Injections with triamcinolone acetonide 40 mg/ml were performed in the wrist region (10-40 mg per joint and tendon sheath) \[[@B9]\]. US-guided injections were done by the free-hand technique using a small 12-5 MHz linear hockey-stick transducer, visualizing the position of the needle in real time. The needle (23 G) was inserted along the US plane into joint recesses or tendon sheaths. The dorsal radio-carpal and midcarpal recesses were punctured in a longitudinal scanning plane. The needle was inserted obliquely in a proximal direction in the axis of the joint recesses (Figure [3a-c](#F3){ref-type="fig"}), and more tangentially, controlling the needle position by an additional transverse US scan, during injection in the tendon sheaths. Aiming to minimize the risk of subcutaneous atrophy, the needle was flushed with lidocaine before withdrawal and all injections were followed by thorough local compression.

![**US-guided puncture of the dorsal recess of the radio-carpal and midcarpal joints**. **a**Drawing showing the direction of the needle during puncture of the hypertrophic midcarpal recess (rc). Lun = lunate bone, Cap = capitate bone, mc = midcarpal recess. **b**Image of the US-guided puncture of the dorsal midcarpal recess in a JIA patient. **c**Dorsal sagittal US scan showing the tip of the needle (arrows) in the midcarpal recess (mc). Ext = extensor tendon, Lun = lunate bone, Cap = capitate bone, rc = radio-carpal recess.](1546-0096-10-11-3){#F3}

Follow-up after injection
-------------------------

In all patients, the clinical and US assessment was repeated at 1 and 4 weeks after the steroid injection. The ultrasonographer performing the assessments was blinded to clinical data. For the joint recesses and tendon sheaths, the presence (no effect) or absence (normalization) of synovial hypertrophy after treatment was recorded. In the follow-up of synovial hyperemia, residual presence (no effect) or total absence (normalization) of color Doppler flow was noted.

Results
=======

US results before injection
---------------------------

The results of Doppler US before steroid injection are summarized in Table [3](#T3){ref-type="table"}. Synovial hypertrophy was found in 26 compartments and hyperemia in 23 (radio-carpal joints, midcarpal joints, and tendon sheaths). Involvement of multiple compartments was observed in 10 of the 15 wrists, and only five wrists showed isolated radio-carpal involvement. Synovitis was found in 13 (87%) of the radio-carpal joints and eight (53%) of the midcarpal joints. The compartments involved in association with the radio-carpal joint included the midcarpal joint (five wrists), tendon sheaths (two wrists), and both midcarpal joint and tendon sheaths (one wrist). In two wrists, synovial hypertrophy was detected only in the midcarpal joint and tendon sheaths. Tenosynovitis was found in five of the 15 wrists (33%), affecting a total of 5-6 tendons in three of the wrists and 1-2 tendons in two. Of all 135 tendon sheaths examined, 20 (15%) exhibited synovial hypertrophy and 16 (12%) hyperemia on Doppler-US. No patients had tenosynovitis without radio-carpal or midcarpal involvement. The age distribution was similar in patients with, and without, tendon involvement. The respective numbers of extensor and flexor tendons involved are summarized in Table [2](#T2){ref-type="table"}. Color Doppler examination showed synovial hyperemia in 23 of the 26 diseased compartments (88%; Table [3](#T3){ref-type="table"}). Effusion was detected in two of the 21 inflamed joint compartments and in five of the 20 diseased tendon sheaths. Bone erosions were only found in the wrist (in the os *lunatum*) of a 14 year-old girl with oligo JIA and disease duration of 13.5 years.

###### 

US diagnosis of synovial hypertrophy and hyperemia in 15 wrists before steroid injection

  Compartments          Synovialhypertrophy   Synovialhyperemia
  --------------------- --------------------- -------------------
  Radio-carpal joints   13/15 (87%)           12/15 (80%)
                                              
  Midcarpal joints      8/15 (53%)            7/15 (47%)
                                              
  Tendon sheaths        5/15 (33%)            4/15 (27%)
                                              
  All compartments      26/45 (58%)           23/45 (51%)

US-guided steroid injection
---------------------------

US-guided steroid injection was performed in 21 of the 26 diseased compartments (summarized in Table [4](#T4){ref-type="table"}). Four of the diseased tendon sheaths (two flexor and two extensor tendons) were injected. To minimize the procedural pain, injections were done under general anesthesia in younger patients (n = 8, median age 7.5 years) and with nitrous oxide-oxygen analgesia in school-age children (n = 3, median age 15 years). Nine wrists had one injection, and six wrists received two injections. The dose was 40 mg in joints and 10-20 mg in tendon sheaths (1-2 per patient). Four patients had involvement of both wrists, and both sides were injected during the same session. In five patients, other joints (three knees and two talo-crural and subtalar joints, respectively) were injected with triamcinolone hexacetonide (knees) or triamcinolone acetonide (ankle regions) during the same session. In the individual patients, the total steroid dose injected ranged from 30 to 80 mg (median 40 mg), and the US-guided steroid injection including general anesthesia took approximately 30 min (5-15 min for the steroid injection, depending on the number and sites of injections).

###### 

US diagnosis of synovial hypertrophy and hyperemia 1 week and 4 weeks after US-guided injection of corticosteroids

                                              1 week post-injection      4 weeks post-injection                              
  --------------------- --------------------- -------------------------- ------------------------ -------------------------- ------------------------
  **Compartments**      **Number injected**   **Synovial hypertrophy**   **Synovial hyperemia**   **Synovial hypertrophy**   **Synovial hyperemia**
                                                                                                                             
  Radio-carpal joints   12                    6/12 (50%)                 3/12 (25%)               2/12 (17%)                 1/12 (8%)
                                                                                                                             
  Midcarpal joints      5                     3/5 (60%)                  0/5 (0%)                 1/5 (20%)                  1/5 (20%)
                                                                                                                             
  Tendon sheaths        4                     0/4 (0%)                   0/4 (0%)                 0/4 (0%)                   0/4 (0%)
                                                                                                                             
  All compartments      21                    9/21 (43%)                 3/21 (14%)               3/21 (14%)                 2/21 (9%)

At the time of steroid injection, new systemic therapies were started in three of the patients: one of these children was previously untreated and was given methotrexate; one had previously received methotrexate and was switched to sulphasalazine; the third was receiving methotrexate as single therapy, and etanercept was added.

US follow-up of steroid injection
---------------------------------

US-guidance of injections enabled real-time visualization of the procedure and allowed quick and effective placement of the needle tip and steroid in all compartments. The effects on synovial hypertrophy and hyperemia in 21 injected compartments 1 and 4 weeks after treatment are shown in Table [4](#T4){ref-type="table"}. After 1 week, normalization of synovial hypertrophy was noted in 57% of the injected compartments, and normalization of hyperemia was seen in 86% (Table [4](#T4){ref-type="table"}); corresponding rates after 4 weeks were 86% and 91% (Table [4](#T4){ref-type="table"}), respectively. After 4 weeks, Doppler-US demonstrated persistent synovitis in injected compartments in two wrists: one in a 13-year-old girl with ERA who had synovial hypertrophy without hyperemia in the radio-carpal joint; the other in a 15-year-old boy with poly JIA who showed synovial hypertrophy with hyperemia in the radio-carpal and midcarpal joints of the same wrist. The midcarpal joint was normalized on US follow-up 1 week after injection but displayed a relapse of synovial hypertrophy and hyperemia after 4 weeks. Twenty compartments (16 tendon sheaths, one radio-carpal joint, and three midcarpal joints) had US signs of disease at week 0 but were not injected. At the 4-week US follow-up, only one joint (midcarpal) exhibited residual synovial hypertrophy and hyperemia (Figure [4a-e](#F4){ref-type="fig"}).

![**Dorsal sagittal US scans of the radio-carpal and midcarpal recesses**. **a, b**Hypoechoic rounded radio-carpal (rc) and midcarpal (mc) recesses (**a**) with hyperemia on the color Doppler examination (**b**). Lun = lunate bone, Cap = capitate bone. **c**US-guided puncture with the tip of the needle (arrow) in the radio-carpal recess (rc). Lun = lunate bone, Cap = capitate bone, mc = midcarpal recess. **d, e**Four-week US follow-up of a midcarpal recess (mc) not treated with steroid injection, showing persistent synovial hypertrophy (**d**) and hyperemia (**e**). Lun = lunate bone, Cap = capitate bone.](1546-0096-10-11-4){#F4}

At clinical follow-up 1 week after injection, eight wrists were completely free from all signs of active arthritis (joint swelling or limitation in the range of joint movement accompanied by pain or tenderness), and seven wrists still exhibited clinically active arthritis. Four weeks after injection, normalization was achieved in 12 wrists, whereas three wrists had clinically active arthritis, two in a 13-year-old girl with ERA and one in a 6-year-old girl with poly JIA.

Relapses
--------

A 14-year-old girl with oligo JIA was the only patient with a recurrence of symptoms in an injected wrist compartment, and this was noted 7 months after the initial steroid injection. A relapse of synovitis was verified by Doppler-US, and the wrist was re-injected with steroids under US-guidance, which led to normalization of symptoms at the clinical follow-up 1 month later.

Complications
-------------

The only complication noted was local subcutaneous atrophy at the injected site (radio-carpal joint) in one patient, a 9-year-old girl. This represents a complication rate of 4.8%.

Discussion
==========

There are no validated US scoring systems for the assessment of inflammatory and joint damage abnormalities in JIA, and there is little knowledge of the normal US reference values of each joint at different developmental stages in children. In this study we used the OMERACT definitions for US pathology in adult RA \[[@B7]\], and the presence/absence of these signs of pathology were registered for each of the compartments examined. Recent investigations have demonstrated that clinical examination alone is inadequate to identify structures involved in JIA, and that subclinical synovitis is frequently detected by US \[[@B10],[@B11]\], particularly in the hands and feet \[[@B12],[@B13]\]. In the present US study, we were able to diagnose synovitis in such compartments, which are difficult to assess clinically \[[@B12],[@B13]\] (Table [3](#T3){ref-type="table"}).

We conducted a descriptive investigation, which was not designed to compare the results of clinical and US assessments. In symptomatic wrists, the radio-carpal and midcarpal joints were often involved (in 87% and 53%, respectively). Diseased tendon sheaths were found in only one third of the wrists, which can be compared with such findings in 55% of the symptomatic ankles examined by Doppler-US in one of our previous studies \[[@B14]\]. In contrast, our observation of synovial hyperemia in 88% of the diseased compartments (Table [3](#T3){ref-type="table"}) is comparable to our findings in the ankle region (89%) \[[@B14]\] and to previous results showing hyperemia in 93% of symptomatic MCP joints \[[@B15]\] and 77% of symptomatic knees \[[@B16]\] in JIA patients. Effusion was infrequent in our patients, especially in the joint compartments.

Steroid injections constitute a major form of treatment in JIA, at disease onset or during the course of the disease \[[@B17]\]. The clinical effect of such an injection depends on accurate placement of the steroid in the diseased compartment. Imaging-guidance can significantly improve the accuracy, and US is the best available technique for guided injections \[[@B18]-[@B24]\]. Indeed, in a number of studies significantly better results were obtained using imaging-guided injections, compared to palpation-guided injections, in treatment of adults with arthritis/osteoarthritis in large and small joints \[[@B18],[@B25]\] and of children with arthritis in the ankle region \[[@B26]\]. Common clinical practice in JIA with wrist swelling has been to perform a palpation-guided injection in the radio-carpal joint, whereas injection of the midcarpal joints or tendon sheaths is done less frequently.

To our knowledge, our study is the first to describe US-guided steroid injections in the wrist region in JIA. Inasmuch as US-guidance of injections in this region is an established practice at the Pediatric Rheumatology Outpatient Clinic, Rigshospitalet, we considered it unethical to randomize patients to either palpation-guided or US-guided injections.

Follow-up of treatment efficacy in arthritis patients is based on clinical examination and imaging. US follow-up after steroid injection or other treatments in rheumatology has been scrutinized in several studies of adults but only a few investigations of children \[[@B27]-[@B30]\]. Moreover, all JIA studies thus far have focused on the knee and hip. Doppler-US is widely used for follow-up in adult rheumatology, whereas the literature contains only three JIA studies in which this technique was used to evaluate treatment efficacy after steroid injections in the ankle region \[[@B14]\] or in knee synovitis after systemic corticosteroids \[[@B16]\] and NSAIDs \[[@B31]\]. Our study is the first to describe Doppler-US for follow-up of steroid injections in the wrist region in JIA patients. Table [4](#T4){ref-type="table"} illustrates the effect of US-guided steroid injections on synovial hypertrophy and hyperemia. In joints, normalization of hyperemia was faster than normalization of synovial hypertrophy. In tendon sheaths, complete normalization of both synovial hyperemia and hypertrophy, appeared already 1 week after steroid injection. Previous studies of JIA have shown that US and Doppler-US are more sensitive than clinical examination alone \[[@B10]-[@B13]\]. In the present investigation, Doppler-US revealed persistent synovitis in injected compartments in two wrists (two patients) at 4-week follow-up, and one of those wrists did not exhibit any clinical signs of active arthritis. At the same time point, results of US examination were completely normal for one of the three wrists with clinically active arthritis. Most compartments that did not receive steroid injections showed normalization 4 weeks after treatment, with the exception of one midcarpal joint. Arthrographic studies of the wrist region in children are lacking, and thus it is uncertain whether the mentioned beneficial effects were due to the existence of anatomical communications between joint compartments and tendon sheaths, or to systemic absorption of steroid. Furthermore, a number of patients received pharmacological treatments with a potential impact on the course of the disease and some received concomitant steroid injections in other joints, which might have biased the follow-up of steroid injections.

Subcutaneous atrophy is a well-recognized adverse effect of intra-articular steroid injection in pediatric patients, and it occurs most likely in small or complex joints such as the wrist or ankle in children under 4 years of age \[[@B32]\] or when a larger injection volume is used \[[@B33]\]. When employing US-guidance, as in our study, the needle tip is always correctly localized before injection, which minimizes extravasation of steroid into the subcutaneous tissue. Despite the precautions taken (see methods section for details), subcutaneous atrophy did occur in one of our patients.

US detects synovial hypertrophy as a solid, non-compressible, hypoechoic tissue in connection with joint lines or surrounding tendons \[[@B7]\]. Detection is more challenging in younger children than in adolescents and adults, because in the former group the synovial tissue is difficult to distinguish from the hypoechoic cartilage of the epiphyses. Therefore, to avoid diagnostic errors, it is imperative to have good knowledge of the normal age-dependent US appearance of each joint (Figure [5a-c](#F5){ref-type="fig"}) and also to use a meticulous scanning technique that allows clear interpretation of possible anisotropic artifacts (Figure [6a-b](#F6){ref-type="fig"}). The presence of juxta-articular flow at color Doppler examination in a growing child can represent either the flow of the well-vascularized cartilage of the epiphysis or synovial hyperemia reflecting disease activity.

![**To avoid diagnostic errors, it is important to have good knowledge of the normal US appearance of age-related ossification of cartilaginous carpal bones in young children**. **a**Dorsal sagittal US scan of the wrist in a 6-year-old girl showing a normal hypoechoic cartilaginous lunate bone (\*); mc3 = metacarpal 3. **b**Palmar transversal US scan of the wrist in a 4-year-old boy showing a normal hypoechoic cartilaginous hook of the hamate (\*). **c**Palmar transversal US scan of the wrist in a 2-year-old girl showing a normal hypoechoic cartilaginous pisiform bone (\*) and a hypertrophic hypoechoic piso-triquetral recess (syn).](1546-0096-10-11-5){#F5}

![**Anisotropic artifacts in US scans of wrists of JIA patients**. **a**Dorso-ulnar longitudinal US scan of the wrist in a 14-year-old girl showing a normal large hypoechoic space (\*) that was difficult to analyze due to anisotropy; mc5 = metacarpal 5. **b**Dorsal sagittal US scan showing a measurement (1) of the hypertrophic dorsal synovial recess of the radio-carpal joint. Due to anisotropy, it was difficult to differentiate between the hypoechoic synovial recess and the hypoechoic cartilage of the navicular bone. When the US beam was angled perpendicular to the surface of the cartilage, the interface between synovium and cartilage was visualized (arrow) as a small hyperechoic reflection.](1546-0096-10-11-6){#F6}

US is suitable for examination of children of all ages and has certain advantages over MRI in that it is cheaper, mobile, quickly accessible bedside, easy to combine with clinical assessment (interactivity), and non-invasive. It does not require sedation, which facilitates repeated examinations for follow-up. Assessment of multiple locations is possible during a single session. Agitation of the patient is rarely a problem, and young children can be seated on a parent\'s lap or play while being examined. Modern high-frequency US transducers provide unsurpassed resolution of the superficial musculoskeletal structures in children. Doppler-US adds further information by depicting articular and para-articular soft tissue hyperemia \[[@B10],[@B31]\]. The Doppler signal reflects disease activity in RA, correlating to clinical and laboratory data \[[@B34]\], MRI results \[[@B35]\], and histology \[[@B36]\]. Even though only a few studies have considered the use of Doppler-US for evaluation of synovial hyperemia in JIA, four investigations have demonstrated a correlation between a high synovial Doppler signal and clinical activity \[[@B8],[@B15],[@B16],[@B37]\]. Various systems, involving quantitative or semi-quantitative methods, are used to grade the Doppler flow. In a recent US study, synovial vascularization was absent in healthy controls, and Doppler flow of any grade was significantly associated with clinical synovitis in JIA \[[@B8]\]. In the current study, we assessed synovial vascularization based on the presence or absence of color Doppler flow.

A weakness of the present study is that the US assessments, were evaluated for accuracy by only one experienced musculoskeletal radiologist. Furthermore, our US examination protocol did not include the radio-ulnar joint, and hence we cannot rule out any synovitis in this compartment. Accordingly, in the future we will use a revised and more appropriate scanning protocol for juvenile arthritis that includes the radio-ulnar joint.

Conclusions
===========

Our results highlight the value of US in pediatric rheumatology. US provided information on the exact anatomical location of inflamed structures in the wrist region, and disease was frequently found in compartments that are difficult to evaluate clinically. Also, US enabled exact guidance of steroid injections with a low rate of subcutaneous atrophy, and it was well suited for follow-up examinations. Furthermore, normalization of synovial hypertrophy and hyperemia was achieved in most cases and with few relapses, which suggests that US assessment prior to steroid injection and US-guidance of injections in this complex region have the potential to improve treatment efficacy.
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